Literature DB >> 31112088

Using Artificial Intelligence to Revise ACR TI-RADS Risk Stratification of Thyroid Nodules: Diagnostic Accuracy and Utility.

Benjamin Wildman-Tobriner1, Mateusz Buda1, Jenny K Hoang1, William D Middleton1, David Thayer1, Ryan G Short1, Franklin N Tessler1, Maciej A Mazurowski1.   

Abstract

Background Risk stratification systems for thyroid nodules are often complicated and affected by low specificity. Continual improvement of these systems is necessary to reduce the number of unnecessary thyroid biopsies. Purpose To use artificial intelligence (AI) to optimize the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS). Materials and Methods A total of 1425 biopsy-proven thyroid nodules from 1264 consecutive patients (1026 women; mean age, 52.9 years [range, 18-93 years]) were evaluated retrospectively. Expert readers assigned points based on five ACR TI-RADS categories (composition, echogenicity, shape, margin, echogenic foci), and a genetic AI algorithm was applied to a training set (1325 nodules). Point and pathologic data were used to create an optimized scoring system (hereafter, AI TI-RADS). Performance of the systems was compared by using a test set of the final 100 nodules with interpretations from the expert reader, eight nonexpert readers, and an expert panel. Initial performance of AI TI-RADS was calculated by using a test for differences between binomial proportions. Additional comparisons across readers were conducted by using bootstrapping; diagnostic performance was assessed by using area under the receiver operating curve. Results AI TI-RADS assigned new point values for eight ACR TI-RADS features. Six features were assigned zero points, which simplified categorization. By using expert reader data, the diagnostic performance of ACR TI-RADS and AI TI-RADS was area under the receiver operating curve of 0.91 and 0.93, respectively. For the same expert, specificity of AI TI-RADS (65%, 55 of 85) was higher (P < .001) than that of ACR TI-RADS (47%, 40 of 85). For the eight nonexpert radiologists, mean specificity for AI TI-RADS (55%) was also higher (P < .001) than that of ACR TI-RADS (48%). An interactive AI TI-RADS calculator can be viewed at http://deckard.duhs.duke.edu/∼ai-ti-rads . Conclusion An artificial intelligence-optimized Thyroid Imaging Reporting and Data System (TI-RADS) validates the American College of Radiology TI-RADS while slightly improving specificity and maintaining sensitivity. Additionally, it simplifies feature assignments, which may improve ease of use. © RSNA, 2019 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2019        PMID: 31112088     DOI: 10.1148/radiol.2019182128

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

Review 1.  Overview of Noninterpretive Artificial Intelligence Models for Safety, Quality, Workflow, and Education Applications in Radiology Practice.

Authors:  Yasasvi Tadavarthi; Valeria Makeeva; William Wagstaff; Henry Zhan; Anna Podlasek; Neil Bhatia; Marta Heilbrun; Elizabeth Krupinski; Nabile Safdar; Imon Banerjee; Judy Gichoya; Hari Trivedi
Journal:  Radiol Artif Intell       Date:  2022-02-02

Review 2.  Updates on the Management of Thyroid Cancer.

Authors:  Katherine A Araque; Sriram Gubbi; Joanna Klubo-Gwiezdzinska
Journal:  Horm Metab Res       Date:  2020-02-10       Impact factor: 2.936

3.  Comparison of British Thyroid Association, American College of Radiology TIRADS and Artificial Intelligence TIRADS with histological correlation: diagnostic performance for predicting thyroid malignancy and unnecessary fine needle aspiration rate.

Authors:  Linda Watkins; Greg O'Neill; David Young; Claire McArthur
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.039

4.  Convolutional Neural Network to Stratify the Malignancy Risk of Thyroid Nodules: Diagnostic Performance Compared with the American College of Radiology Thyroid Imaging Reporting and Data System Implemented by Experienced Radiologists.

Authors:  G R Kim; E Lee; H R Kim; J H Yoon; V Y Park; J Y Kwak
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-13       Impact factor: 4.966

5.  Incorporation of a Machine Learning Algorithm With Object Detection Within the Thyroid Imaging Reporting and Data System Improves the Diagnosis of Genetic Risk.

Authors:  Shuo Wang; Jiajun Xu; Aylin Tahmasebi; Kelly Daniels; Ji-Bin Liu; Joseph Curry; Elizabeth Cottrill; Andrej Lyshchik; John R Eisenbrey
Journal:  Front Oncol       Date:  2020-11-12       Impact factor: 6.244

Review 6.  Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives.

Authors:  Ling-Rui Li; Bo Du; Han-Qing Liu; Chuang Chen
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

7.  Deep learning model for multi-classification of infectious diseases from unstructured electronic medical records.

Authors:  Mengying Wang; Zhenhao Wei; Mo Jia; Lianzhong Chen; Hong Ji
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-16       Impact factor: 2.796

8.  TIRADS Management Guidelines in the Investigation of Thyroid Nodules; Illustrating the Concerns, Costs, and Performance.

Authors:  Tom James Cawood; Georgia Rose Mackay; Penny Jane Hunt; Donal O'Shea; Stephen Skehan; Yi Ma
Journal:  J Endocr Soc       Date:  2020-03-10

9.  Accuracy and Effects of Clinical Decision Support Systems Integrated With BMJ Best Practice-Aided Diagnosis: Interrupted Time Series Study.

Authors:  Liyuan Tao; Chen Zhang; Lin Zeng; Shengrong Zhu; Nan Li; Wei Li; Hua Zhang; Yiming Zhao; Siyan Zhan; Hong Ji
Journal:  JMIR Med Inform       Date:  2020-01-20

Review 10.  The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis.

Authors:  Pierpaolo Trimboli; Marco Castellana; Arnoldo Piccardo; Francesco Romanelli; Giorgio Grani; Luca Giovanella; Cosimo Durante
Journal:  Rev Endocr Metab Disord       Date:  2020-09-21       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.